Basics: short version, verdict first People Molecules Peptides Biomarkers Studies Stem Cells Editorial Methodology
← All ingredients
Natural rapalog / Anti-inflammatory

Salicin · Salicin (Willow Bark Extract)

A willow bark compound with mild mTOR-modulating and anti-inflammatory activity; sometimes called a natural rapamycin analog.

D
Evidence grade
Mostly animal

Short answer

Interesting as a mild natural mTOR modulator, but the evidence is far weaker than for rapamycin. Low risk at typical doses. Long-term safety data is limited.

Product and dose overview

Salicin (Salicin (Willow Bark Extract)) is a natural rapalog / anti-inflammatory with evidence grade D, meaning it is primarily supported by animal studies. We track 1 products containing Salicin. Typical doses range from 100 to 100 mg per serving. The top-ranked product scores 4.7 out of 10 on our composite scale (dose, evidence, price, testing, transparency). Prices range up to $49.00 per month.

Evidence grade: D Products in database: 1 Category: Natural rapalog / Anti-inflammatory

Top Salicin products

ProductBrandDosePrice/mo3rd-party testedScore
Natural RapalogsSupersmart100 mg$49.00No4.7

Scores are editorial judgments, not a scientific standard. See how we score.

What it is

Salicin is the active compound in willow bark, the natural precursor to aspirin. Some researchers classify it as a natural rapalog because it appears to modulate mTOR signaling, the same pathway targeted by rapamycin.

Why people take it

Willow bark has been used for anti-inflammatory purposes for centuries. The mTOR connection is primarily mechanistic and animal-based. No human trials on longevity endpoints exist.

Our verdict

Interesting as a mild natural mTOR modulator, but the evidence is far weaker than for rapamycin. Low risk at typical doses. Long-term safety data is limited.

Structure & class

2-(Hydroxymethyl)phenyl-beta-D-glucopyranoside. A phenolic glycoside from Salix species. Metabolized in vivo to salicylic acid. Also shows partial mTORC1 inhibition in cell studies.

Mechanism & clinical data

In vitro studies show salicin and its derivatives inhibit mTORC1 signaling, though weakly compared to rapamycin. Human data is limited to anti-inflammatory analgesic studies. No longevity outcome data.

Pharmacokinetics

Salicylic acid half-life 2 to 4 hours; parent compound metabolized rapidly.

Dose & forms

Trial dose
100 mg
/ day
Range in trials
60 to 240 mg
/ day
Common forms
Capsule (willow bark extract), Powder

What to watch out for

Do not combine with NSAIDs or blood thinners. Some people are allergic to salicylates. Quality varies between willow bark extract suppliers.

Where this dose comes from

The trial dose above is our editorial pick from the published human trials for this ingredient. We choose the dose that the best-available studies used on the endpoint most relevant to longevity. The range shows the lowest and highest doses tested in published trials. The landmark studies below are the papers we read to set it. You can click through and check our work.

When new trials publish, our automated sweeps flag them. If a new study materially changes the dose, we update it through editorial review and record the old dose, new dose, and the triggering study in every affected product's recommendation history. The dose is never changed automatically.

Regulatory status

EUTraditional herbal medicinal product
USDietary supplement
UKTraditional herbal remedy
CANHP

Timeline

Regulatory events, evidence grade changes, and key research milestones for Salicin, most recent first. Studies link to the paper; regulatory entries name and link the responsible authority.

  • 2025-04 Regulatory single source
    EU Court sharpens the bar for botanical health claims
    A Court of Justice of the European Union ruling in April 2025 further tightened the requirements for how botanical ingredients (herbs, plant extracts) can be marketed with health claims in the EU, effectively removing much of the flexibility of the on-hold list.
  • 2024-06 Regulatory confirmed
    EU report identifies 117 supplement substances as potential health risks
    The HoA Working Group on Food Supplements (26 European countries) published its first report evaluating 117 substances used in food supplements. Of these, 65 were assessed as likely novel foods, 6 were already regulated, 34 had insufficient data, and 12 were prioritized for Article 8 restriction under Regulation (EC) No 1925/2006. The 12 priority substances include ashwagandha, curcumin, melatonin, piperine, St. John's wort, coumarin, p-synephrine, maca, holy basil, Melaleuca, black cohosh, and L-tryptophan. The report drew on 1,500 RASFF alerts reviewed between 2017 and mid-2022.
  • 2009 Research milestone
    Vlachojannis 2009 (Phytotherapy Research)
    Systematic review: willow bark extract equivalent to 120 to 240 mg salicin showed modest analgesic efficacy in low-back pain RCTs.
  • 2006-12 Regulatory confirmed
    EU Health Claims Regulation adopted
    Regulation (EC) No 1924/2006 laid down harmonised rules for nutrition and health claims made on foods, including supplements. Only claims listed in the EU Register of authorised claims can be used. Rejected botanical claims are held in a separate on-hold list.
  • 1997 Regulatory confirmed
    EU introduces the Novel Food Regulation
    Regulation (EC) No 258/97 required any food or food ingredient without a history of consumption in the EU before 15 May 1997 to be authorised before being placed on the market. This is the framework that captures NMN, spermidine as a supplement ingredient, urolithin A, and many other longevity actives.

Landmark studies

Found in these products (1)

All products in our catalog that contain Salicin, ranked by our overall score. Ranking is editorial, never paid.

Supersmart
Autophagy
Ingredients listed
5 ingredients listedlargest listed: Curcumin 200 mg
Price per serving
$1.63$49.00 · 30 servings
Testing
None listed

Multi-ingredient bundle

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 4.7/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

40%
of trial dose
$8.17
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with us.supersmart.com
Editorial guides

Buying guides and comparisons

Neighbouring molecules

Related ingredients

See all in Natural rapalog / Anti-inflammatory →

Molecules in the same class, plus the actives most often formulated alongside Salicin in our catalogue.

CurcuminBstacked together in 1 productEGCGCstacked together in 1 productResveratrolCstacked together in 1 productFisetinCstacked together in 1 product

See Salicin in context: the mechanism it acts through, the biomarker it moves, the products that dose it, and the trials that tested it.

View Salicin on the Longevity Map →

Frequently asked questions

What is Salicin?

Salicin is the active compound in willow bark, the natural precursor to aspirin. Some researchers classify it as a natural rapalog because it appears to modulate mTOR signaling, the same pathway targeted by rapamycin.

What dose of Salicin should I take?

The trial dose in published human studies is 100 mg per day, with a range of 60 to 240 mg per day. Always consult a qualified clinician before starting any supplement.

Is Salicin safe?

Do not combine with NSAIDs or blood thinners. Some people are allergic to salicylates. Quality varies between willow bark extract suppliers.

What is the best Salicin supplement?

We track 1 products containing Salicin. The top-ranked product scores 4.7 out of 10 on our composite scale, which evaluates dose, evidence, price, third-party testing, and transparency. See the comparison table above. Scores are editorial judgments, not a scientific standard.

What is the evidence grade for Salicin?

Salicin has evidence grade D, meaning it is primarily supported by animal studies. Grade A means replicated human RCTs with hard endpoints. Grade B means human RCTs with biomarker outcomes. Grade C means mixed or small human trials. See our evidence grading methodology.

Independently checked

Data verification

Evidence grade
D
Mostly animal
Research dose
100 mg
Products tracked
1
Updated continuously
Safety signal
Do not combine with NSAIDs or blood thinners. Some people...

Evidence grades are reviewed when new human RCTs are published. Product counts update automatically as new products are added. Dose ranges reflect published trial data, not brand recommendations. Read how we verify.